SimBioSys

Timeline

1. Sep 25, 2026 FDA FDA 510(k) clearance: TumorSight Risk — K260023, Sep 25, 2026. Applicant at approval: SimBioSys, Inc. source ↗
2. Jul 8, 2025 FDA FDA 510(k) clearance: TumorSight Viz — K251766, Jul 8, 2025. Applicant at approval: SimBioSys, Inc. source ↗
3. Oct 25, 2024 FDA FDA 510(k) clearance: TumorSight Viz — K243189, Oct 25, 2024. Applicant at approval: SimBioSys, Inc. source ↗

FDA records (last 2 years)

• Sep 25, 2026 FDA 510(k) clearance: TumorSight Risk — K260023, Sep 25, 2026. Applicant at approval: SimBioSys, Inc. source ↗
• Jul 8, 2025 FDA 510(k) clearance: TumorSight Viz — K251766, Jul 8, 2025. Applicant at approval: SimBioSys, Inc. source ↗
• Oct 25, 2024 FDA 510(k) clearance: TumorSight Viz — K243189, Oct 25, 2024. Applicant at approval: SimBioSys, Inc. source ↗

NIH awards 3

Annual award amounts. Total $2.6M.

• 2022 NIH contract (government contract; not a grant and not an investment round) 75N91022C00016-0-9999-1 FY2022: $2,000,000 awarded for that fiscal year; activity N44 (OTHER_NIH); PI PETERSON, JOSEPH; recipient as written: SIMBIOSYS, INC., CHICAGO, IL. TOPIC 408: T source ↗
• 2020 NIH contract (government contract; not a grant and not an investment round) 75N91020C00013-0-9999-1 FY2020: $400,000 awarded for that fiscal year; activity N01 (OTHER_NIH); PI PETERSON, JOSEPH; recipient as written: SIMBIOSYS, INC., CHICAGO, IL. SimBioSys Phen source ↗
• 2017 NIH contract (government contract; not a grant and not an investment round) 261201700042C-0-0-1 FY2017: $211,535 awarded for that fiscal year; activity N43 (OTHER_NIH); PI PETERSON, JOSEPH; recipient as written: SIMBIOSYS, INC., CHICAGO, IL. SimBioSys Environm source ↗